Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 456-473, October 2005

Tolerability and safety of rituximab (MabThera®)

  • Eva Kimby

      Affiliations

    • Corresponding Author InformationTel.: +46 8 58 58 00 00; fax: +46 8 7 74 87 25.

Center of Hematology, Karolinska University Hospital, Stockholm, Sweden

published online 29 July 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(05)00101-5

doi:10.1016/j.ctrv.2005.05.007

Cancer Treatment Reviews
Volume 31, Issue 6 , Pages 456-473, October 2005

Article Tools

* Image Usage & Resolution